Terug naar overzicht

NewCompliance secures additional funding with new innovation partner Gentex Corporation

NewCompliance, a pioneering healthcare technology company specializing in surgical workflow optimization and patient safety solutions, announced today that it has received an investment from Gentex Corporation, a global leader in electro-optical technology and digital vision systems. This strategic collaboration establishes Gentex as NewCompliance’s innovation partner, marking a significant step toward developing transformative solutions for the healthcare industry.

Gentex expands its focus on medical technology

Gentex is a technology company and long-time supplier of electro-optical products for the global automotive, aerospace, fire protection and medical industries. The company is best known for automotive electronics, but continues to grow its capabilities in vision systems, sensing, AI development, biometrics, home automation, healthcare, and more. By investing in NewCompliance, Gentex is expanding its focus on healthcare by continuing to look for innovative technologies that can revolutionize the industry. 

“We see incredible potential in combining Gentex’s proven expertise in advanced electronic systems with NewCompliance’s innovative healthcare solutions,” said Robert Vance, Gentex’s vice president of new markets. “This partnership underscores our commitment to leveraging our core competencies in digital vision and connectivity to solve real-world challenges. Together, we aim to deliver groundbreaking technologies that enhance surgical workflows and improve patient outcomes.” 

NewCompliance has established itself as a leader in healthcare technology by integrating real-time data to improve operational efficiencies and safety in surgical environments. The partnership with Gentex will enable both companies to pool their resources and expertise to develop next-generation solutions tailored to the evolving needs of healthcare providers. 

“This is a transformational moment for NewCompliance,” said Steve Ross, CEO at NewCompliance. “With Gentex’s support and shared focus on innovation, we can expand our impact, improving healthcare systems and outcomes for patients worldwide.” 

NewCompliance believes Gentex’s strategic focus on the convergence of its core technologies, such as digital vision, sensing, connectivity, and dimmable glass, positions the company as an ideal partner. The investment provides NewCompliance not only with funding, but also a partner with a broad vision and the technical resources to drive further innovation. In addition to Gentex’s investment, InnovationQuarter Capital is also supporting this funding round, providing NewCompliance not only with financial resources but also access to strategic expertise and a network that drives innovation in the healthcare sector.

Nieuwsbrief